IP Library Assignment 055631/0039
Patent Assignment
Reel/Frame 055631/0039

Assignment of Assignor's Interest

Recorded: 2021-03-18 Pages: 3
Assignors
ZHENG, ZHENHUAN
Executed: 2021-03-17
LEE, TIEN-LI
Executed: 2021-03-17
Assignee
AARDVARK THERAPEUTICS INC
12707 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO, CALIFORNIA, 92130
Covered Property (1)
Oral Delayed Burst Formulation of Naloxone or Low-Dose Naltrexone
Application: 63/088,416 →
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 29, 2021
From: AARDVARK THERAPEUTICS, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 058230/0170 →
Corrective Assignment to Correct the Assignee from Aardvark Therapeutics Inc to Aardvark Therapeutics, Inc & Update Address of Assignee Previously Recorded at Reel: 055631 Frame: 0039. Assignor(S) Hereby Confirms the Assignee. Nov 29, 2021
From: ZHENG, ZHENHUAN; LEE, TIEN-LI
To: AARDVARK THERAPEUTICS, INC.
Reel/Frame 058263/0850 →
Confirmatory Assignment Nov 29, 2021
From: AARDVARK THERAPEUTICS, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 058732/0085 →
Confirmatory Assignment Nov 29, 2021
From: ZHENG, ZHENHUAN; LEE, TIEN-LI
To: AARDVARK THERAPEUTICS, INC.
Reel/Frame 058957/0358 →
Assignment of Assignor's Interest Jun 29, 2022
From: SORRENTO THERAPEUTICS, INC.
To: SCILEX HOLDING COMPANY
Reel/Frame 060543/0060 →